Skip to main content
SpringerLink
Log in

Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The cartilage oligomeric matrix protein (COMP) is a glycoprotein, which occurs mainly in an articular cartilage. The amount of this protein increases under the influence of cytokines and growth factors. As a result of various diseases that cause damage to cartilage, fragments of matrix protein are released into synovial fluid and then into blood. The assessment of matrix protein level in serum, for example COMP, permits the establishment of the degree of cartilage damage in inflammatory joint diseases, and permits observation of the effectiveness of the treatment. Blood was collected from 30 systemic lupus erythematosus (SLE) patients, and from 30 patients with knee osteoarthritis (OA) who constituted the control group. Serum COMP level was determined using an inhibition enzyme-linked immunosorbent assay (ELISA). The average value of the serum COMP level in SLE patients was 11.3±3.7 U/l. According to correlation coefficients, serum COMP level is independent of patients’ age, disease duration and the clinical picture of SLE. No correlation was found between serum COMP level and bone mass density (BMD) changes. In SLE patients with decreased haemoglobin levels (<11.0 g/dl) values compared with patients with normal haemoglobin level, the serum COMP level was observed to be significantly higher (P<0.05). Both in SLE patients with erythrocyte sedimentation rate (ESR) values over 60 mm/h and in patients with ESR values below 60 mm/h, the serum COMP level was observed to be significantly higher (P<0.05). A significant positive correlation was found between serum COMP level and ESR value, as well as a number of thrombocytes. Negative correlation occurred between the serum COMP level and the value of haemoglobin. The average value of COMP in OA patients was 10.4±2.7 U/l. No correlation was found between serum COMP level and patients’ age and disease duration. There was correlation between the serum COMP level and the T-score value of densitometry examinations in OA patients. No statistical differences were found between the average serum COMP levels for SLE and OA patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Saxne T, Heinegard D (1992)Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 31:583–591

    CAS  PubMed  Google Scholar 

  2. Morgelin M. Heinegard D, Engel J, Paulsson M (1992) Electron microscopy of native cartilage oligomeric matrix protein purified from the swam rat chondrosarcoma reveals a five-armed structure. J Biol Chem 267:6137–6141

    CAS  PubMed  Google Scholar 

  3. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, Sommarin Y, Wendel M, Oldberg A, Heinegard D (1992) Cartilage matrix proteins: an acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 267:6132–6136

    CAS  PubMed  Google Scholar 

  4. Franzen A, Heinegard D, Solursh M (1997) Evidence for sequential appearance of cartilage matrix proteins in developing mouse limbs and in cultures of mouse mesenchymal cells. Differentiation 36:199–210

    Google Scholar 

  5. DiCesare P, Morgelin M, Mann K, Paulsson M (1994) Cartilage oligomeric matrix protein and trombospondin. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. Eur J Biochem 223:927–937

    CAS  PubMed  Google Scholar 

  6. Neihart M, Hauser N, Paulsson M, Dicesare PE, Michel BA, Hauselmann HJ (1997) Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 36:1151–1160

    Article  CAS  PubMed  Google Scholar 

  7. Wollheim FA, Eberhardt KB, Johnson U, Saxne T (1997) HLA DRB1* typing and cartilage oligometric matrix protein (COMP) as predictors of joint destruction in recent-onset rheumatoid arthritis. Br J Rheumatol 36:847–849

    Article  CAS  PubMed  Google Scholar 

  8. Mansson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole AR, Heinegard D, Saxne T (1995) Cartilage and metabolism in rheumatoid arthritis. J Clin Invest 95:1071–1077

    CAS  PubMed  Google Scholar 

  9. Forslind K, Eberhardt K, Jonsson A, Saxne T (1992) Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Br J Rheumatol 31:593–598

    CAS  PubMed  Google Scholar 

  10. Lindquist EK, Saxne T, Eberhard K (2002) Relationship between functional capacity, disease activity, pain and joint destruction during the first 10 years of rheumatoid arthritis. Ann Rheum Dis 61(suppl 1):74

    Google Scholar 

  11. Fex E, Eberhardt K, Saxne T (1997) Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet. Br J Rheumatol 36: 161–166

    Google Scholar 

  12. Peterson IF, Boegard T, Dahlstrom J, Svensson B, Heinegard D, Saxne T (1996) Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis. Osteoarthr Cartilage 6:33–39

    Google Scholar 

  13. Vilim V, Olejarova M, Machacek S, Gatterova J, Kraus VB, Pavelka K (2002) Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthr Cartilage 10:707–713

    Google Scholar 

  14. Haberhauer GF, Feyertag J, Kittl EM, Bauer K, Dunky A (2002) Steroid treatment normalises the varialibity and levels of serum COMP in RA patients, indicating a possibility to monitor effect of cartilage protective drugs. Rheum Dis 61(suppl 1):200

    Google Scholar 

  15. Haberhauer GF, Feyertag J, Kitti EM, Bauer K, Dunky A (2003) Rapid decrease of COMP serum levels in patients with active RA undergoing IV steroid treatment. Ann Rheum Dis 62(suppl1):166

    Google Scholar 

  16. Crnkic M, Masson B, Larsson L, Geborek P, Heinegard D, Saxne T (2003) Serum Cartilage Oligomeric Matrix Protein (COMP) decreased in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther 5:R181–R185

    Article  CAS  PubMed  Google Scholar 

  17. Den Broeder AA, Jonsten LAB, Saxne T, Heinegard D, Fenner H, Miltenburg AMM, Frasa WLH, van Tils LJ, Buurman WA, van Riel PLCM, van de Putte LBA, Barrera P (2002) Long term anti-tumor necrosis factor alfa monotherapy in rheumatoid arthritis: effect on radiological course and endothelial activation. Ann Rheum Dis 61:311–318

    Article  CAS  PubMed  Google Scholar 

  18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rotthfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    CAS  PubMed  Google Scholar 

  19. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritris Rheum 40:1725

    Google Scholar 

  20. Altman R (1991) Classification of disease: osteoarthritis. Semin Arthritis Rheum 21(suppl 2):40–47

    Article  Google Scholar 

  21. Emlen W, O’Neill LO (1997) Clinical significance of antinuclear antibodies. Comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays. Arthritis Rheum 40:1612–1618

    Google Scholar 

  22. Robert R, Sokal F, Rohlf J (1986) Biometry. Freeman, New York, pp 354–359, 691–714

  23. Heinegard D, Oldberg A (1989) Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J 3:2042–2051

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Central Clinical Hospital, Woloska 137, 02-507, Warsaw, Poland

    M. Wisłowska & B. Jabłońska

Authors
  1. M. Wisłowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Jabłońska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Wisłowska.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wisłowska, M., Jabłońska, B. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication. Rheumatol Int 25, 373–378 (2005). https://doi.org/10.1007/s00296-004-0581-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-004-0581-7

Keywords

Search

Navigation